â??Clinical Study on the Efficacy of Phalatrikadi Ghanavati in the Management of Madhumehajanya Medoroga With Special Reference to Diabetic Dyslipidaemiaâ??

ational Institute of Ayurveda0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1. Patients willing to sign the consent form.
•2. Patients between the age group of 20-60 years of either sex.
•3. Diagnosed and confirmed cases of Dyslipidemia in Diabetes Mellitus Type II patients (based on NCEP-Adult treatment panel III guideline) Total Cholesterol (TC) > 200 mg/dl, Triglyceride (TG) > 150 mg/dl, Low Density Lipoprotein (LDL) > 130 mg/dl, High Density Lipoprotein (HDL) < 40 mg/dl, Fasting blood sugar (FBS) <140 mg/dl, Post Prandial blood sugar (PPBS) < 200 mg/dl.

•1. Patients having Type - DM I [IDDM]
•2. Patient of type II DM who are on Insulin therapy.
•3. DM with Coronary Artery Diseases (CAD), Malignancy or any other serious illness.
•4. DM with serious complications.
•5. Diabetes Insipidus.
•6. Drug induced DM.
•7. Fasting Blood Sugar >140mg/dl.
•8. Postprandial Blood Sugar >200mg/dl.
•9. Uncontrolled Hypertension (systolic blood pressure >150 mm of Hg and /or Diastolic blood pressure >100 mm of Hg).

发起方